{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:11:41Z","timestamp":1793319101652,"version":"4.5.0"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:p>\n                    Refractory celiac disease type II (RCD II), also referred to as \u201ccryptic\u201d enteropathy-associated T-cell lymphoma (EATL) or \u201cintraepithelial T-cell lymphoma,\u201d is a rare clonal lymphoproliferative disorder that arises from innate intraepithelial lymphocytes. RCD II has a poor prognosis and frequently evolves to EATL. The pathogenesis of RCD II is not well understood and data regarding the immunophenotypic spectrum of this disease and underlying genetic alterations are limited. To gain further biological insights, we performed comprehensive immunophenotypic, targeted next-generation sequencing, and chromosome microarray analyses of 11 RCD II cases: CD4\n                    <jats:sup>\u2212<\/jats:sup>\n                    \/CD8\n                    <jats:sup>\u2212<\/jats:sup>\n                    (n=6), CD8\n                    <jats:sup>+<\/jats:sup>\n                    (n=4), and CD4\n                    <jats:sup>+<\/jats:sup>\n                    (n=1), and 2 of 3 ensuing EATLs. Genetic alterations were identified in 9\/11 (82%) of the RCD II cases. All 9 displayed mutations in members of the JAK-STAT signaling pathway, including frequent, recurrent\n                    <jats:italic toggle=\"yes\">STAT3<\/jats:italic>\n                    (7\/9, 78%) and\n                    <jats:italic toggle=\"yes\">JAK1<\/jats:italic>\n                    (4\/9, 44%) mutations, and 9\/10 evaluable cases expressed phospho-STAT3. The mutated cases also harbored recurrent alterations in epigenetic regulators (\n                    <jats:italic toggle=\"yes\">TET2<\/jats:italic>\n                    , n=5 and\n                    <jats:italic toggle=\"yes\">KMT2D<\/jats:italic>\n                    , n=5), nuclear factor-\u03baB (\n                    <jats:italic toggle=\"yes\">TNFAIP3<\/jats:italic>\n                    , n=4), DNA damage repair (\n                    <jats:italic toggle=\"yes\">POT1<\/jats:italic>\n                    , n=3), and immune evasion (\n                    <jats:italic toggle=\"yes\">CD58<\/jats:italic>\n                    , n=2) pathway genes. The CD4\n                    <jats:sup>\u2212<\/jats:sup>\n                    \/CD8\n                    <jats:sup>\u2212<\/jats:sup>\n                    and other immunophenotypic subtypes of RCD II exhibited similar molecular features. Longitudinal genetic analyses of 4 RCD II cases revealed stable mutation profiles, however, additional mutations were detected in the EATLs, which occurred at extraintestinal sites and were clonally related to antecedent RCD II. Chromosome microarray analysis demonstrated copy number changes in 3\/6 RCD II cases, and 1 transformed EATL with sufficient neoplastic burden for informative analysis. Our findings provide novel information about the immunophenotypic and genomic characteristics of RCD II, elucidate early genetic events in EATL pathogenesis, and reveal potential therapeutic targets.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000001658","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T12:21:50Z","timestamp":1612786910000},"page":"905-916","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":49,"title":["Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II"],"prefix":"10.1097","volume":"45","author":[{"given":"Craig R.","family":"Soderquist","sequence":"first","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne K.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro A.","family":"Gru","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Virginia, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Vlad","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli S.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Virginia, Charlottesville, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh M.","family":"Mansukhani","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Bacchi","sequence":"additional","affiliation":[{"name":"Bacchi Laboratory, Pathology Reference Laboratory, Botucatu, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bachir","family":"Alobeid","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Medicine, Celiac Disease Center, Columbia University Irving Medical Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/apt.12606","article-title":"Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease","volume":"39","author":"Ilus","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2011-301346","article-title":"The Oslo definitions for coeliac disease and related terms","volume":"62","author":"Ludvigsson","year":"2013","journal-title":"Gut"},{"key":"R3-20250608","first-page":"509","article-title":"Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma","volume":"146","author":"Murray","year":"1995","journal-title":"Am J Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1182\/blood.V92.10.3879","article-title":"Are complicated forms of celiac disease cryptic T-cell lymphomas?","volume":"92","author":"Carbonnel","year":"1998","journal-title":"Blood"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0016-5085(98)70530-X","article-title":"Abnormal intestinal intraepithelial lymphocytes in refractory sprue","volume":"114","author":"Cellier","year":"1998","journal-title":"Gastroenterology"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.V94.1.260.413k40_260_264","article-title":"Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population","volume":"94","author":"Bagdi","year":"1999","journal-title":"Blood"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bpg.2005.02.001","article-title":"Refractory coeliac disease","volume":"19","author":"Daum","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","article-title":"Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II","volume":"136","author":"Malamut","year":"2009","journal-title":"Gastroenterology"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11899-018-0459-5","article-title":"Pathogenesis of enteropathy-associated T cell lymphoma","volume":"13","author":"Chander","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2016.07.018","article-title":"Interleukin-15-dependent T-cell-like innate intraepithelial lymphocytes develop in the intestine and transform into lymphomas in celiac disease","volume":"45","author":"Ettersperger","year":"2016","journal-title":"Immunity"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-012-0322-z","article-title":"Refractory celiac disease: from bench to bedside","volume":"34","author":"Malamut","year":"2012","journal-title":"Semin Immunopathol"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0016-5085(03)00692-9","article-title":"Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue","volume":"125","author":"Verkarre","year":"2003","journal-title":"Gastroenterology"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2559.2000.00926.x","article-title":"Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method","volume":"37","author":"Patey-Mariaud De Serre","year":"2000","journal-title":"Histopathology"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clim.2007.09.002","article-title":"Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in refractory celiac disease","volume":"126","author":"Verbeek","year":"2008","journal-title":"Clin Immunol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/PAS.0b013e318159b478","article-title":"Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype","volume":"32","author":"De Mascarel","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"9896","DOI":"10.3390\/nu7125506","article-title":"Recognising and managing refractory coeliac disease: a tertiary centre experience","volume":"7","author":"Nasr","year":"2015","journal-title":"Nutrients"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2468-1253(19)30265-1","article-title":"Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study","volume":"4","author":"Cellier","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/his.12251","article-title":"Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward\u2014report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology","volume":"64","author":"Attygalle","year":"2013","journal-title":"Histopathology"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0753-3322(01)80003-2","article-title":"Histopathology of celiac disease","volume":"54","author":"Oberhuber","year":"2000","journal-title":"Biomed Pharmacother"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/path.1506","article-title":"Loss of heterozygosity at chromosome 9p21 is a frequent finding in enteropathy-type T-cell lymphoma","volume":"202","author":"Obermann","year":"2004","journal-title":"J Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1182\/blood.V83.11.3271.3271","article-title":"Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas","volume":"83","author":"Bottaro","year":"1994","journal-title":"Blood"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"37636","DOI":"10.18632\/oncotarget.9400","article-title":"Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders","volume":"7","author":"Margolskee","year":"2016","journal-title":"Oncotarget"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hon.2720","article-title":"Refractory celiac disease type II: an atypical case highlighting limitations of the current classification system","volume":"38","author":"Soderquist","year":"2020","journal-title":"Hematol Oncol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/apt.13755","article-title":"Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry","volume":"44","author":"Rubio-Tapia","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3748\/wjg.v17.i4.506","article-title":"Evaluation of cladribine treatment in refractory celiac disease type II","volume":"17","author":"Tack","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/cyto.b.20481","article-title":"Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization","volume":"76","author":"Verbeek","year":"2009","journal-title":"Cytometry B Clin Cytom"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","article-title":"Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study","volume":"45","author":"Malamut","year":"2013","journal-title":"Dig Liver Dis"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/gut.51.3.372","article-title":"Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression","volume":"51","author":"Farstad","year":"2002","journal-title":"Gut"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/gut.49.6.804","article-title":"Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue","volume":"49","author":"Daum","year":"2001","journal-title":"Gut"},{"key":"R32-20250608","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/(SICI)1097-0320(19980415)34:2<95::AID-CYTO6>3.0.CO;2-B","article-title":"Flow cytometry description of a novel CD3\u2212\/CD7+ intraepithelial lymphocyte subset in human duodenal biopsies: potential diagnostic value in coeliac disease","volume":"34","author":"Eiras","year":"1998","journal-title":"Cytometry"},{"key":"R33-20250608","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MEG.0b013e3282f16a4b","article-title":"Flow cytometric analysis of intestinal intraepithelial lymphocytes in the diagnosis of refractory celiac sprue","volume":"20","author":"Sanchez-Mu\u00f1oz","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R34-20250608","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.20060028","article-title":"Reprogramming of CTLs into natural killer-like cells in celiac disease","volume":"203","author":"Meresse","year":"2006","journal-title":"J Exp Med"},{"key":"R35-20250608","doi-asserted-by":"crossref","first-page":"681.e10","DOI":"10.1053\/j.gastro.2015.05.013","article-title":"Distinct and synergistic contributions of epithelial stress and adaptive immunity to functions of intraepithelial killer cells and active celiac disease","volume":"149","author":"Setty","year":"2015","journal-title":"Gastroenterology"},{"key":"R36-20250608","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2559.2005.02237.x","article-title":"T-bet expression patterns in coeliac disease, cryptic and overt enteropathy-type T-cell lymphoma","volume":"47","author":"J\u00f6hrens","year":"2005","journal-title":"Histopathology"},{"key":"R37-20250608","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jclinpath-2018-205023","article-title":"Clonal T cell receptor gene rearrangements in coeliac disease: Implications for diagnosing refractory coeliac disease","volume":"71","author":"Hussein","year":"2018","journal-title":"J Clin Pathol"},{"key":"R38-20250608","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.molimm.2012.01.014","article-title":"Origin and immunophenotype of aberrant IEL in RCDII patients","volume":"50","author":"Tack","year":"2012","journal-title":"Mol Immunol"},{"key":"R39-20250608","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/gutjnl-2014-308153","article-title":"The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease","volume":"65","author":"Schmitz","year":"2016","journal-title":"Gut"},{"key":"R40-20250608","doi-asserted-by":"crossref","first-page":"E980","DOI":"10.1073\/pnas.1620036114","article-title":"CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes","volume":"114","author":"Kooy-Winkelaar","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"R41-20250608","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.molimm.2013.10.014","article-title":"Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients","volume":"58","author":"Schmitz","year":"2014","journal-title":"Mol Immunol"},{"key":"R42-20250608","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"R43-20250608","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"R44-20250608","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/leu.2015.263","article-title":"Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia","volume":"30","author":"Andersson","year":"2016","journal-title":"Leukemia"},{"key":"R45-20250608","first-page":"360","article-title":"Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant\u2013associated ALCL","volume":"135","author":"Laurent","year":"2020","journal-title":"Blood"},{"key":"R46-20250608","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1038\/ncomms12602","article-title":"Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations","volume":"7","author":"Roberti","year":"2016","journal-title":"Nat Commun"},{"key":"R47-20250608","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20160894","article-title":"Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2","volume":"214","author":"Moffitt","year":"2017","journal-title":"J Exp Med"},{"key":"R48-20250608","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/leu.2016.178","article-title":"Mutations in the JAK\/STAT and RAS signaling pathways are common in intestinal T-cell lymphomas","volume":"30","author":"Nicolae","year":"2016","journal-title":"Leukemia"},{"key":"R49-20250608","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/leu.2016.13","article-title":"JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma","volume":"30","author":"Nairism\u00e4gi","year":"2016","journal-title":"Leukemia"},{"key":"R50-20250608","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3324\/haematol.2019.230961","article-title":"Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract","volume":"105","author":"Soderquist","year":"2020","journal-title":"Haematologica"},{"key":"R51-20250608","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"R52-20250608","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cell.2013.11.020","article-title":"Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation","volume":"155","author":"Hu","year":"2013","journal-title":"Cell"},{"key":"R53-20250608","doi-asserted-by":"crossref","first-page":"eaau6986","DOI":"10.1126\/sciadv.aau6986","article-title":"TET2 coactivates gene expression through demethylation of enhancers","volume":"4","author":"Wang","year":"2018","journal-title":"Sci Adv"},{"key":"R54-20250608","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ni.3517","article-title":"Emerging concepts of epigenetic dysregulation in hematological malignancies","volume":"17","author":"Ntziachristos","year":"2016","journal-title":"Nat Immunol"},{"key":"R55-20250608","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"key":"R56-20250608","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"R57-20250608","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-biochem-051710-134100","article-title":"The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis","volume":"81","author":"Shilatifard","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"R58-20250608","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"R59-20250608","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3324\/haematol.2017.182444","article-title":"Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified","volume":"103","author":"Ji","year":"2018","journal-title":"Haematologica"},{"key":"R60-20250608","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MOH.0000000000000249","article-title":"The many layers of epigenetic dysfunction in B-cell lymphomas","volume":"23","author":"Jiang","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"R61-20250608","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrc2775","article-title":"A20: from ubiquitin editing to tumour suppression","volume":"10","author":"Hymowitz","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R62-20250608","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.29697","article-title":"Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia","volume":"138","author":"Johansson","year":"2016","journal-title":"Int J Cancer"},{"key":"R63-20250608","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"key":"R64-20250608","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.celrep.2016.05.008","article-title":"Telomere replication stress induced by POT1 inactivation accelerates tumorigenesis","volume":"15","author":"Pinzaru","year":"2016","journal-title":"Cell Rep"},{"key":"R65-20250608","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"key":"R66-20250608","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"key":"R67-20250608","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/gcc.22276","article-title":"Alterations of the CD58 gene in classical Hodgkin lymphoma","volume":"54","author":"Schneider","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"R68-20250608","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"R69-20250608","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"R70-20250608","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1038\/s41467-020-19402-8","article-title":"Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients","volume":"11","author":"Fernando","year":"2020","journal-title":"Nat Commun"},{"key":"R71-20250608","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/blood.2018874560","article-title":"Targeting glycogen synthase kinase 3 for therapeutic benefit in lymphoma","volume":"134","author":"Wu","year":"2019","journal-title":"Blood"},{"key":"R72-20250608","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.immuni.2007.10.014","article-title":"Acquisition of a functional T cell receptor during T lymphocyte development is enforced by HEB and E2A transcription factors","volume":"27","author":"Jones","year":"2007","journal-title":"Immunity"},{"key":"R73-20250608","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0002-9440(10)64441-0","article-title":"Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma","volume":"161","author":"Zettl","year":"2002","journal-title":"Am J Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T18:03:19Z","timestamp":1749405799000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":73,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001658","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,2]]}}}